NICE Announced Review Of Its Skin Cancer Guidance

The National Institute for Health and Clinical Excellence (NICE) has announced that it see fit convene a guidance development group to formally review the recommendations relating to the diagnosis and move of 'low risk' basal cell carcinomas (BCCs) in primary care in its leadership Improving Outcomes in Cancer for people with skin tumours including melanoma (2003).

Antiquated in 2009 NICE was made aware of difficulties arising from the implementation of one circumstance of its guidance. These were particularly in relation to the arrangements under which GPs could rub out 'low risk' BCCs and how services for skin cancer patients were being commissioned. Some GPs believed that the requirements, mainly attendance at hospital multidisciplinary team meetings, were unnecessarily onerous and in some areas it was believed that there was a intimation to GP minor surgery in general. As a result of these concerns, NICE held a converging in April 2009, chaired by the National Cancer Director, Professor Mike Richards and including representatives of some of the key stakeholder groups confused in implementing the NICE guidance including the Royal College of General Practitioners (RCGP), British Medical Syndicate and British Association of Dermatology (BAD). A number of important issues were clarified at this meet but NICE feels that further formal review is needed.
Dr Fergus Macbeth, Head of the Centre for Clinical Practice at NICE, said: "It is vital that patients are accurately diagnosed, clear appropriate treatment and avoid unnecessary or incomplete surgery. We have listened to the concerns of our stakeholders relative to the difficulty of implementing the recommendations in the guidance around the diagnosis and removal of low hazard BCCs in primary care.
We have in the offing also taken into account the fact that the management of overlay conditions in general is an important part of all GPs' workload, for which they are trained, and that all GPs may warrant some minor procedures - such as curettage, cryotherapy and electrocautery - within their elementary contract, and some GPs also carry out 'minor surgery'. It is impressive to point out that neither the original guidance nor any revisions to it will switch this situation. What the expert group will specifically make allowance for are the recommendations in the NICE guidance about the diagnosis and removal of low risk BCCs in firsthand care. Therefore, the recommendation in the guidance that patients with a suspected bitter melanoma, squamous cell carcinoma or high risk BCC should be referred to the Town Skin Cancer Multidisciplinary Team for diagnosis and management will not be reviewed."

2009 © Copyright. All Rights Reserved.